drugset / Trial / NCT02112643

Selenium in Mild Thyroid Eye Disease in North America

NCT02112643 ↗

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine whether sodium selenite is helpful in the treatment of mild thyroid eye disease in North America.

Timeline

Start
2015-10
Primary completion
2016-11-16
Completion
2016-11-16

Outcome

Outcome not reported

Stopped (Business): “Lack of funding”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sodium selenate Small molecule 100 ug Oral